Position in XENE
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$63,553,994
+$20,854,922 QoQ
Shares Held
1,092,932
+14.7% QoQ
Ownership
1.13%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in XENE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GEODE CAPITAL MANAGEMENT, LLC holds $18,583,356,554 across 528 Biotechnology names. XENE ranks #55 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,139,621 | $2,741,586,360 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
2,607,732 | $2,014,838,051 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,660,385 | $880,241,584 | |
| 4 | INSM |
INSMED Inc
|
4,450,389 | $727,727,608 | |
| 5 | MRNA |
Moderna, Inc.
|
9,435,132 | $479,304,705 | |
| 6 | INCY |
Incyte Corp
|
4,703,184 | $442,663,677 | |
| 7 | RPRX |
Royalty Pharma plc
|
7,869,632 | $377,506,246 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
4,918,030 | $365,212,906 |
All Filings in XENE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $63,553,994 | 1,092,932 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $42,699,072 | 952,679 | Shares | Defined | 2026-02-09 | |
| 2025-09-30 | $39,244,014 | 977,435 | Shares | Defined | 2025-11-12 | |
| 2025-06-30 | $30,371,735 | 970,343 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $2,334,979 | 69,597 | Shares | Defined | 2025-05-13 | |
| 2024-12-31 | $2,725,536 | 69,529 | Shares | Defined | 2025-02-12 | |
| 2024-09-30 | $2,709,010 | 68,809 | Shares | Defined | 2024-11-12 | |
| 2024-06-30 | $2,687,541 | 68,929 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $2,765,058 | 64,229 | Shares | Defined | 2024-05-13 | |
| 2023-12-31 | $2,859,082 | 62,073 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $1,911,081 | 55,945 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,152,727 | 55,915 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $1,994,397 | 55,725 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $2,179,887 | 55,285 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $2,231,810 | 61,823 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $1,384,596 | 45,516 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $862,012 | 28,198 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $880,905 | 28,198 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $330,812 | 21,650 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $403,123 | 21,650 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $344,431 | 19,242 | Shares | Defined | 2021-05-12 | |
| 2020-12-31 | $295,941 | 19,242 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $213,008 | 19,242 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $241,294 | 19,242 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $218,204 | 19,242 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||